Detalhe da pesquisa
1.
A decade of clinical development of PARP inhibitors in perspective.
Ann Oncol
; 30(9): 1437-1447, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218365
2.
The Influence of Donor and Recipient Gender Incompatibility on Corneal Transplant Rejection and Failure.
Am J Transplant
; 17(1): 210-217, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412098
3.
Phase I trial outcomes in older patients with advanced solid tumours.
Br J Cancer
; 114(3): 262-8, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757260
4.
Progress in the treatment of ovarian cancer-lessons from homologous recombination deficiency-the first 10 years.
Ann Oncol
; 27 Suppl 1: i1-i3, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141062
5.
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.
Ann Oncol
; 27(8): 1449-55, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037296
6.
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.
Br J Cancer
; 112(7): 1157-65, 2015 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25719834
7.
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.
Br J Cancer
; 113(11): 1541-7, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554652
8.
A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer.
Ann Oncol
; 25(10): 1988-1995, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070546
9.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608201
10.
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma.
Br J Cancer
; 108(8): 1553-9, 2013 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23558892
11.
New developments in the treatment of ovarian cancer--future perspectives.
Ann Oncol
; 24 Suppl 10: x69-x76, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24265409
12.
Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients.
Ann Oncol
; 24(11): 2813-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114859
13.
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer.
Ann Oncol
; 24(1): 145-52, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23002282
14.
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.
Ann Oncol
; 24(3): 679-87, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041585
15.
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
Br J Cancer
; 106(4): 619-28, 2012 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22281664
16.
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
Br J Cancer
; 107(11): 1797-800, 2012 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23099802
17.
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
Br J Cancer
; 107(7): 1025-30, 2012 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910320
18.
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experience.
Ann Oncol
; 23(8): 1968-1973, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22408187
19.
Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials.
Oncology
; 83(4): 177-82, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889980
20.
Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC).
Gynecol Oncol
; 125(1): 31-6, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22082991